< Back to catalogue

Smartscope-X - Affordable, accessible and automatic screening solution for diabetic retinopathy

  • Research and Innovation
  • Global
  • Edge
Last updated: 2021-09-15 06:35

Strategic Goals

As the number of diabetics grows, so too does the number of people who suffer from diabetic retinopathy (DR). Caused by damage to the blood vessels in the tissues at the back of the eye, DR is the most common cause of vision loss in working-age adults.

Solutions Developed / Used

Smartscope-X consists of three main components: a low-cost handheld fundus camera, an automated screening algorithm and cloud service for fundus images. With this unique combination, Optomed’s vision is to bring affordable, accessible and automatic DR screening available for all diabetics. In this project, the key ambition is to validate and commercialise Smartscope-X solution.

Description

Start Date 01/08/2017
End Date 30/04/2020
Geographical Scope
  • Global
Keywords
  • Edge
Cloud Delivery Model
  • IaaS
  • PaaS
  • SaaS
Project Life-Cycle Stage
  • Research and Innovation
Industry
  • Health
Technology
  • Artificial Intelligence / Machine Learning

Stakeholders


    Industry
  • Finland
    OPTOMED OY (Finland)


EU Contribution
  • €1,971,935.00
Overall Budget
  • €2,817,050.00
Official Website